Cargando…

Salivary Antioxidants and Oxidative Stress in Psoriatic Patients: Can Salivary Total Oxidant Status and Oxidative Status Index Be a Plaque Psoriasis Biomarker?

The aim of our research was to evaluate redox balance parameters and biomarkers of oxidative stress (OS) in nonstimulated and stimulated saliva as well as the blood of patients with plaque psoriasis compared to healthy controls. The study involved 40 patients with plaque psoriasis and 40 generally h...

Descripción completa

Detalles Bibliográficos
Autores principales: Skutnik-Radziszewska, Anna, Maciejczyk, Mateusz, Fejfer, Katarzyna, Krahel, Julita, Flisiak, Iwona, Kołodziej, Urszula, Zalewska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964728/
https://www.ncbi.nlm.nih.gov/pubmed/31998446
http://dx.doi.org/10.1155/2020/9086024
_version_ 1783488510485856256
author Skutnik-Radziszewska, Anna
Maciejczyk, Mateusz
Fejfer, Katarzyna
Krahel, Julita
Flisiak, Iwona
Kołodziej, Urszula
Zalewska, Anna
author_facet Skutnik-Radziszewska, Anna
Maciejczyk, Mateusz
Fejfer, Katarzyna
Krahel, Julita
Flisiak, Iwona
Kołodziej, Urszula
Zalewska, Anna
author_sort Skutnik-Radziszewska, Anna
collection PubMed
description The aim of our research was to evaluate redox balance parameters and biomarkers of oxidative stress (OS) in nonstimulated and stimulated saliva as well as the blood of patients with plaque psoriasis compared to healthy controls. The study involved 40 patients with plaque psoriasis and 40 generally healthy subjects matched by age and gender to the study group patients. We assayed the concentration/activity of antioxidant enzymes: salivary peroxidase (Px), catalase (CAT), and superoxide dismutase (SOD) measured in unstimulated saliva (NWS), stimulated saliva (SWS), and erythrocytes. In plasma as well as NWS and SWS, we measured the concentration/activity of reduced glutathione (GSH), total antioxidant potential (TAC), total oxidative status (TOS), oxidative stress index (OSI), and markers of oxidative modification of proteins: advanced glycation end products (AGE), advanced oxidation protein products (AOPP), and lipid oxidation products: malondialdehyde (MDA) and total lipid hydroperoxide (LOOH). In NWS and SWS, we also evaluated the rate of reactive oxygen species (ROS) production. The concentration of Px, CAT, and SOD was significantly higher in NWS of patients with plaque psoriasis vs. healthy subjects. In SWS of psoriatic patients, we observed considerably higher concentration of Px and CAT, and in erythrocytes of patients with plaque psoriasis, the concentration of GPx and CAT was significantly higher compared to that in the controls. The levels of AOPP, AGE, MDA, and LOOH were considerably higher in NWS, SWS, and plasma of the study group compared to the controls. The concentration of total protein and salivary amylase was significantly lower in NWS and SWS of psoriatic patients compared to the healthy control. In the course of plaque psoriasis, we observed redox imbalances with prevalence of oxidation reactions. Mechanisms involved in the synthesis/secretion of proteins and activity of amylase were depressed in both glands of psoriatic patients; however, they were more inhibited in the parotid gland compared to the submandibular gland. TOS concentration and OSI value in NWS and SWS may serve as diagnostic biomarkers of plaque psoriasis.
format Online
Article
Text
id pubmed-6964728
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-69647282020-01-29 Salivary Antioxidants and Oxidative Stress in Psoriatic Patients: Can Salivary Total Oxidant Status and Oxidative Status Index Be a Plaque Psoriasis Biomarker? Skutnik-Radziszewska, Anna Maciejczyk, Mateusz Fejfer, Katarzyna Krahel, Julita Flisiak, Iwona Kołodziej, Urszula Zalewska, Anna Oxid Med Cell Longev Research Article The aim of our research was to evaluate redox balance parameters and biomarkers of oxidative stress (OS) in nonstimulated and stimulated saliva as well as the blood of patients with plaque psoriasis compared to healthy controls. The study involved 40 patients with plaque psoriasis and 40 generally healthy subjects matched by age and gender to the study group patients. We assayed the concentration/activity of antioxidant enzymes: salivary peroxidase (Px), catalase (CAT), and superoxide dismutase (SOD) measured in unstimulated saliva (NWS), stimulated saliva (SWS), and erythrocytes. In plasma as well as NWS and SWS, we measured the concentration/activity of reduced glutathione (GSH), total antioxidant potential (TAC), total oxidative status (TOS), oxidative stress index (OSI), and markers of oxidative modification of proteins: advanced glycation end products (AGE), advanced oxidation protein products (AOPP), and lipid oxidation products: malondialdehyde (MDA) and total lipid hydroperoxide (LOOH). In NWS and SWS, we also evaluated the rate of reactive oxygen species (ROS) production. The concentration of Px, CAT, and SOD was significantly higher in NWS of patients with plaque psoriasis vs. healthy subjects. In SWS of psoriatic patients, we observed considerably higher concentration of Px and CAT, and in erythrocytes of patients with plaque psoriasis, the concentration of GPx and CAT was significantly higher compared to that in the controls. The levels of AOPP, AGE, MDA, and LOOH were considerably higher in NWS, SWS, and plasma of the study group compared to the controls. The concentration of total protein and salivary amylase was significantly lower in NWS and SWS of psoriatic patients compared to the healthy control. In the course of plaque psoriasis, we observed redox imbalances with prevalence of oxidation reactions. Mechanisms involved in the synthesis/secretion of proteins and activity of amylase were depressed in both glands of psoriatic patients; however, they were more inhibited in the parotid gland compared to the submandibular gland. TOS concentration and OSI value in NWS and SWS may serve as diagnostic biomarkers of plaque psoriasis. Hindawi 2020-01-03 /pmc/articles/PMC6964728/ /pubmed/31998446 http://dx.doi.org/10.1155/2020/9086024 Text en Copyright © 2020 Anna Skutnik-Radziszewska et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Skutnik-Radziszewska, Anna
Maciejczyk, Mateusz
Fejfer, Katarzyna
Krahel, Julita
Flisiak, Iwona
Kołodziej, Urszula
Zalewska, Anna
Salivary Antioxidants and Oxidative Stress in Psoriatic Patients: Can Salivary Total Oxidant Status and Oxidative Status Index Be a Plaque Psoriasis Biomarker?
title Salivary Antioxidants and Oxidative Stress in Psoriatic Patients: Can Salivary Total Oxidant Status and Oxidative Status Index Be a Plaque Psoriasis Biomarker?
title_full Salivary Antioxidants and Oxidative Stress in Psoriatic Patients: Can Salivary Total Oxidant Status and Oxidative Status Index Be a Plaque Psoriasis Biomarker?
title_fullStr Salivary Antioxidants and Oxidative Stress in Psoriatic Patients: Can Salivary Total Oxidant Status and Oxidative Status Index Be a Plaque Psoriasis Biomarker?
title_full_unstemmed Salivary Antioxidants and Oxidative Stress in Psoriatic Patients: Can Salivary Total Oxidant Status and Oxidative Status Index Be a Plaque Psoriasis Biomarker?
title_short Salivary Antioxidants and Oxidative Stress in Psoriatic Patients: Can Salivary Total Oxidant Status and Oxidative Status Index Be a Plaque Psoriasis Biomarker?
title_sort salivary antioxidants and oxidative stress in psoriatic patients: can salivary total oxidant status and oxidative status index be a plaque psoriasis biomarker?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964728/
https://www.ncbi.nlm.nih.gov/pubmed/31998446
http://dx.doi.org/10.1155/2020/9086024
work_keys_str_mv AT skutnikradziszewskaanna salivaryantioxidantsandoxidativestressinpsoriaticpatientscansalivarytotaloxidantstatusandoxidativestatusindexbeaplaquepsoriasisbiomarker
AT maciejczykmateusz salivaryantioxidantsandoxidativestressinpsoriaticpatientscansalivarytotaloxidantstatusandoxidativestatusindexbeaplaquepsoriasisbiomarker
AT fejferkatarzyna salivaryantioxidantsandoxidativestressinpsoriaticpatientscansalivarytotaloxidantstatusandoxidativestatusindexbeaplaquepsoriasisbiomarker
AT kraheljulita salivaryantioxidantsandoxidativestressinpsoriaticpatientscansalivarytotaloxidantstatusandoxidativestatusindexbeaplaquepsoriasisbiomarker
AT flisiakiwona salivaryantioxidantsandoxidativestressinpsoriaticpatientscansalivarytotaloxidantstatusandoxidativestatusindexbeaplaquepsoriasisbiomarker
AT kołodziejurszula salivaryantioxidantsandoxidativestressinpsoriaticpatientscansalivarytotaloxidantstatusandoxidativestatusindexbeaplaquepsoriasisbiomarker
AT zalewskaanna salivaryantioxidantsandoxidativestressinpsoriaticpatientscansalivarytotaloxidantstatusandoxidativestatusindexbeaplaquepsoriasisbiomarker